Bullboard Post History

by ScienceFirst

Order by:

V.TLT	RE:88% TR @90-days if you exclude 10 of the undertreated ScienceFirst - (2/20/2023 6:35:29 PM) 88% TR @90-days if you exclude... April 18, 2023
V.TLT	RE:70% CR @90-days if you exclude 10 of the undertreated ScienceFirst - (2/20/2023 6:20:13 PM) 70% CR @90-days if you exclude... April 18, 2023
T.PYR	RE:RE:RE:And the uptrend continues. Tamarakflop ... Still half-stories??? Your call on EXRO bsuting the 3$ mark... April 18, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:I don't see a mystery Gman620 ... Merck and all the littrature posted on the AUA, IBCN, BCAN all... April 18, 2023
V.TLT	RE:RE:RE:RE:RE:I don't see a mystery Eoganacht ... Nice observation. IRBX N-803 has no future as a stand... April 18, 2023
V.TLT	RE:New Theory That would explain why BUNGE is also making a comeback. He hates Roger... April 18, 2023
V.TLT	RE:RE:RE:About to KABOOM on both US and Canada sides BUNGE ... It's the final destination that matters. Especially in... April 18, 2023
V.TLT	RE:RE:About to KABOOM on both US and Canada sides BUNGE ... Your wife allows you to get back on Internet??? Always as... April 18, 2023
T.PYR	Tamarackflop flagged as condescending on EXRO board Tamarackflop has a poir credibility and attitude, even on EXRO board! if... April 18, 2023
V.TLT	RE:RE:GSK buys Bellus for 2B$ to challenge MERCK’s market Donein25 ... That's indeed the main reason I posted this article. ... April 18, 2023
V.TLT	RE:Are you guys getting any responses from the company? MD&A in 10 days. New set of data will probably be integrated in a... April 18, 2023
V.TLT	GSK buys Bellus for 2B$ to challenge MERCK’s market Another example that shows how big pharmas think and what they're ready... April 18, 2023
T.PYR	8 posts alone yesterday from Tamarackflop The guy has an obvious agenda. A vendetta. No doubt. 800... April 18, 2023
V.TLT	RE:Keytruda = $265,000 (17 doses per year) Not impressive ... on any fronts Gemcitabine + Docetaxel = $172,000 (6... April 17, 2023
V.TLT	RE:Repost from Jan 15 about Immunitybio Efficacy Interesting to notice that 2 of our Ph. 2 clinical study sites (CSS) have... April 17, 2023
V.TLT	RE:Repost from Jan 15 about Immunitybio Efficacy Eoganact ... Great post, as always. Thanks for sharing. ___________... April 17, 2023
V.TLT	Up and down and up and down and up and down Looking at the 1y chart, the share price has been manipulated, so many times.... April 17, 2023
V.TLT	RE:IBRX up ~50% over last week The 1y target for the response of the FDA to IBRX is May 25. It might... April 17, 2023
T.PYR	RE:ARK Investment Management LLC Date of transaction is March 31, so 2 weeks ago. ARK... April 17, 2023
V.TLT	RE:Or perhaps there's a PP underway BlueFranky ... Good possible explanation. But no matter what it is, the... April 17, 2023

Become a member today, It's free!

Bullboard Post History

by ScienceFirst

RE:88% TR @90-days if you exclude 10 of the undertreated

RE:70% CR @90-days if you exclude 10 of the undertreated

RE:RE:RE:And the uptrend continues.

RE:RE:RE:RE:RE:RE:RE:I don't see a mystery

RE:RE:RE:RE:RE:I don't see a mystery

RE:New Theory

RE:RE:RE:About to KABOOM on both US and Canada sides

RE:RE:About to KABOOM on both US and Canada sides

Tamarackflop flagged as condescending on EXRO board

RE:RE:GSK buys Bellus for 2B$ to challenge MERCK’s market

RE:Are you guys getting any responses from the company?

GSK buys Bellus for 2B$ to challenge MERCK’s market

8 posts alone yesterday from Tamarackflop

RE:Keytruda = $265,000 (17 doses per year)

RE:Repost from Jan 15 about Immunitybio Efficacy

RE:Repost from Jan 15 about Immunitybio Efficacy

Up and down and up and down and up and down

RE:IBRX up ~50% over last week

RE:ARK Investment Management LLC

RE:Or perhaps there's a PP underway

Featured Company

Algernon Pharmaceuticals Inc. C.AGN

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by ScienceFirst

Featured Company